|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Total net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Selling, general and administrative expenses | |||||
| Research and development costs | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other income (expense): | |||||
| Interest and dividend income | |||||
| Unrealized gain (loss) on marketable equity investments | |||||
| Gain on sale of investments | |||||
| Gain on marketable equity investments, net | |||||
| Interest expense | |||||
| Total other income | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Basic & Diluted income per share: | |||||
| Basic net income per share | |||||
| Diluted net income per share | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...